Help Afib Patients Live Better
Data show that surgical ablation during heart surgery:
- Increases survival
- Reduces risk of stroke
- Lessens post-surgical complications
Concomitant Surgical Ablation Using a Novel Bipolar Radiofrequency Clamp: Outcomes from the TRAC-AF Registry
Shults, C. et al. (2025). J. Clin. Med. doi:10.3390/jcm14238360 Introduction The Tracking Results of...
Three-year Outcomes of the Postapproval Study of the AtriCure Bipolar Radiofrequency Ablation of Permanent Atrial Fibrillation Trial
The Evidence Is In and Has Been for Years: How The ABLATE Studies Set the Standard and Hold Strong...
Treat the Appendage, Improve Outcomes
Why Surgical Left Atrial Appendage Exclusion Matters in Atrial Fibrillation The Clinical Problem: Af...
Why Thousands of CABG Patients Miss Life-Extending Afib Treatment Every Year – and How Surgeons Can Change That
The 49% All-Cause Death Rate Nobody Talks About14 Only 1 in 10 CABG/AVR Patients with Afi...
Long-Term Follow-Up of Left Atrial Appendage Exclusion: Results of the V-CLIP Multi-Center Post-Market Study
Zias, E. et al. (2025). Journal of Clinical Medicine. doi:10.3390/jcm14155473 Introduction The V-CLI...
A New Beat: How One Surgery Helped Dorsey Reclaim His Rhythm
Dorsey Wheeler, a dedicated music store owner, experienced a decline in his health due to aortic val...
Press Release
AtriCure Reports First Quarter 2026 Financial Results
First Quarter 2026 worldwide revenue of $141.2 million, an increase of 14.3% year over year First Quarter 2026 profitability improved, with net income of $0.1 million and adjusted EBITDA of $17.1 million U.S. revenue growth accelerated to 14.9%, driven by AtriClip FLEX-Mini ®, cryoSPHERE ® MAX ™,






